Mirae Asset Capital Life Science vs Nicole Agnew compared for founders deciding who to pitch. Stage focus, check size, and sector fit compared side by side.
Mirae Asset Capital Life Science is a venture capital based in Boston, MA, USA. Nicole Agnew is a venture capital based in New York across 90 portfolio companies. Sector focus diverges: Mirae Asset Capital Life Science concentrates on Biotech and Healthcare and Nicole Agnew on Artificial Intelligence, Climate Tech and Cybersecurity. On stage, Mirae Asset Capital Life Science is active at Pre Seed, Seed and Series A and Nicole Agnew at undisclosed stages.
Investors like Mirae Asset Capital Life Science · Investors like Nicole Agnew · Mirae Asset Capital Life Science co-investors · Full investor directory
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide